YM 872

Known as: YM-872, YM872 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2017
0246819982017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Zonampanel monohydrate ([2,3-dioxo-7-(1H-imidazol-1-yl)-6-nitro-1,2,3,4-tetrahydro-1-quinoxalinyl] acetic acid monohydrate, YM872… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2006
2006
We examined antiepileptogenic and anticonvulsant effects of [2,3-dioxo-7-(1H-imidazol-1-yl)-6-nitro-1,2,3,4-tetrahydro-1… (More)
Is this relevant?
2004
2004
Zonampanel monohydrate (YM872; [2,3-dioxo-7-(1H-imidazol-1-yl)-6-nitro-1,2,3,4-tetrahydro-1-quinoxalinyl]acetic acid monohydrate… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2002
2002
During cerebral ischaemia, glutamate is released in supraphysiological amounts and is toxic to brain tissue. This excitotoxicity… (More)
Is this relevant?
2000
2000
The neuroprotective effects of YM872 ([2,3-dioxo-7-(1H-imidazol-1-yl)6-nitro-1,2,3,4-tetrahydro-1-quinoxal inyl]acetic acid… (More)
Is this relevant?
1999
1999
UNLABELLED Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antagonists have spinally mediated analgesic… (More)
Is this relevant?
1999
1999
UNLABELLED A new competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, (2,3-dioxo-7-[1H… (More)
Is this relevant?
1998
1998
The in-vitro pharmacological properties of (2,3-dioxo-7-(1H-imidazol-1-yl)-6-nitro-1,2,3,4-tetrahydro-1-quinoxal inyl)-acetic… (More)
Is this relevant?
1998
1998
BACKGROUND AND PURPOSE We recently described an image analysis technique based on the temporal correlation mapping (TCM) of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
1998
1998
The neuroprotective effect of YM872 ([2.3-dioxo-7-(1H-imidazol-1-yl) 6-nitro-1,2,3,4-tetrahydro-1-quinoxalinyl]acetic acid… (More)
Is this relevant?